The man accused of breaking into former House Speaker Nancy Pelosi’s San Francisco home, bludgeoning her husband with a hammer and seeking to kidnap her goes on trial Thursday. Opening ...

Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the new results of an ...

Sep. 16, 2024 — CREME is a virtual laboratory that allows scientists to simulate specific decreases in gene activity. It offers a powerful new tool for identifying and understanding important ...

DePape admitted during trial testimony that he bludgeoned Pelosi with a hammer after San Francisco police officers showed up at the home. David DePape said he went to the Pelosis' home to talk to ...

It is this carefully controlled pattern of what is called "gene expression" that makes a liver cell different from a muscle cell, and a healthy cell different from a cancer cell. But how can ...

Current scientific techniques are not yet safe or effective enough to be used to create gene-edited babies, an international committee says. The technology could one day prevent parents from ...

WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...

The turning on of this single gene results in an apparent freak of nature. Mice whose agouti gene is "on" are also more likely to suffer from diabetes and cancer as adults. The implications of ...

Inheriting two copies of the unpleasant taste gene provides a "ruin-your-day level of bitterness" to foods like broccoli and sprouts, they say. It could explain why some people find it difficult ...

Gene Park is a reporter for The Washington Post, covering video games and gaming culture. He joined The Post in 2015 as audience editor, and is a former reporter in the West Coast and Pacific region.

Fidanacogene elaparvovec, an adeno-associated virus (AAV) gene-therapy vector for hemophilia B containing a high-activity human factor IX variant (FIX-R338L/FIX-Padua), was associated with ...